Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)Jean-Pascal Machiels, Lisa Licitra, Renaud Lhommel et al.|Annals of Oncology|2018Cited by 43
Activity of afatinib administered in a window pre-operative study in squamous cell carcinoma of the head and neck (SCCHN) : EORTC-90111.Jean‐Pascal Machiels, Lisa Licitra, Jessica Menis et al.|Journal of Clinical Oncology|2016Cited by 4
Health and economic outcomes of two different follow up strategies in effectively cured advanced head and neck cancer patientsChiara Villa, Federica Favales, Michela Meregaglia et al.|Annals of Oncology|2016Cited by 1